Belinda A. Mohr is the Lead Health Economist on the Global Health Economics and Outcomes Research Team at W. L. Gore & Associates in Phoenix, AZ. She has conducted several economic evaluations to demonstrate the value of Gore medical devices to multiple stakeholders. Her work has been disseminated in peer-reviewed publications, podium and poster presentations, reimbursement submissions, and sales and marketing tools. Prior to joining Gore, Dr. Mohr was an Economist for the U.S. Food and Drug Administration working on cost-benefit analyses of proposed FDA regulations. She focused on estimating the public health benefits and the costs to FDA regulated industries of implementing the regulations. She holds a Ph.D. and M.A. in Economics from the University of California, Santa Barbara.